Skip to main content

ORIGINAL RESEARCH article

Front. Mol. Biosci.
Sec. Molecular Diagnostics and Therapeutics
Volume 11 - 2024 | doi: 10.3389/fmolb.2024.1505698
This article is part of the Research Topic The Role of Calcium Channels in Human Health and Disease Volume III View all 3 articles

Disparate molecular mechanisms in cardiac ryanodine receptor channelopathies

Provisionally accepted
Yadan Zhang Yadan Zhang 1Monika Seidel Monika Seidel 1Camille Rabesahala De Meritens Camille Rabesahala De Meritens 1Astrid Beckmann Astrid Beckmann 1Syeda Ahmed Syeda Ahmed 1Melanie Hurtz Melanie Hurtz 1F Anthony Lai F Anthony Lai 2Dimitris Parthimos Dimitris Parthimos 3Spyros Zissimopoulos Spyros Zissimopoulos 1*
  • 1 Swansea University Medical School, Swansea, United Kingdom
  • 2 College of Medicine, Qatar University, Doha, Qatar
  • 3 School of Medicine, Cardiff University, Cardiff, United Kingdom

The final, formatted version of the article will be published soon.

    Mutations in the cardiac ryanodine receptor (RyR2) are associated with catecholaminergic polymorphic ventricular tachycardia (CPVT). This study investigates the underlying molecular mechanisms for CPVT mutations within the RyR2 N-terminus domain (NTD).We consulted the high-resolution RyR2 structure in both open and closed configuration to identify mutations G357S/R407I and A77T, which lie within the NTD intra-and inter-subunit interface with the Core Solenoid (CSol), respectively. Their structural and functional roles were compared to R169L, a mutation that lies within the NTD-NTD inter-subunit interface. Using chemical cross-linking and co-immunoprecipitation assays, we show that R169L disrupts NTD tetramerization, while it does not alter the NTD-CSol interaction. Single cell Ca 2+ imaging revealed that R169L increases the number of spontaneous Ca 2+ transients and the proportion of oscillating cells, while reducing the Ca 2+ store content. G357S and R407I do not affect NTD tetramerization, but they also do not alter the NTD-CSol interaction. Functionally, RyR2 G357Sexpressing cells have Ca 2+ handling properties similar to RyR2 WT . A77T enhances the NTD-CSol interaction, while it does not affect NTD tetramerization. Like R169L, A77T also increases the number of spontaneous Ca 2+ transients and the proportion of oscillating cells, and it reduces the Ca 2+ store content. However, unlike R169L that displays Ca 2+ transients of normal amplitude and shorter duration, Ca 2+ transients for A77T are of smaller amplitude and normal duration.The NTD-CSol inter-subunit interface variant, A77T, produces a hyperactive channel by altering a different structure-function parameter to other CPVT mutations within the RyR2 NTD. Reduced NTD-NTD inter-subunit interaction and reinforced NTD inter-subunit interaction with CSol are distinct molecular mechanisms for gain-of-function RyR2 arrhythmogenic mutations.

    Keywords: arrhythmia, calcium cycling, excitation-contraction coupling, Intracellular calcium channel, ryanodine Receptor

    Received: 03 Oct 2024; Accepted: 02 Dec 2024.

    Copyright: © 2024 Zhang, Seidel, Rabesahala De Meritens, Beckmann, Ahmed, Hurtz, Lai, Parthimos and Zissimopoulos. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Spyros Zissimopoulos, Swansea University Medical School, Swansea, United Kingdom

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.